Loading...
The clinical profile of benralizumab in the management of severe eosinophilic asthma
Despite several therapeutic choices, 10–20% of patients with severe uncontrolled asthma do not respond to maximal best standard treatments, leading to a healthcare expenditure of up to 80% of overall costs for asthma. Today, there are new important therapeutic strategies, both pharmacological and in...
Na minha lista:
| Udgivet i: | Ther Adv Respir Dis |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
SAGE Publications
2016
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5933597/ https://ncbi.nlm.nih.gov/pubmed/27612492 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1753465816667659 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|